Stocks and Investing
Stocks and Investing
Thu, August 16, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 15, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Konstantinos Aprilakis Maintained (ANAB) at Buy with Decreased Target to $153 on, Aug 15th, 2018
Konstantinos Aprilakis of JMP Securities, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Decreased Target from $180 to $153 on, Aug 15th, 2018.
Konstantinos has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with Konstantinos's Rating of Hold.
This is the rating of the analyst that currently disagrees with Konstantinos
- Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $104 on, Thursday, July 19th, 2018